Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A2 | P23975 | 15/20 | 0.38 |
| ▸ | SLC6A4 | P31645 | 14/20 | 0.38 |
| ▸ | SLC6A3 | Q01959 | 8/20 | 0.38 |
| ▸ | MLNR | O43193 | 1/20 | 0.35 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.35 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.35 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.35 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.35 |
| ▸ | HTR2C | P28335 | 1/20 | 0.35 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.35 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | HRH1 | P35367 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27513995 | 0.90 | SLC6A2 (0.40) | SLC6A2SLC6A4SLC6A3MLNRADRB2 | |
| SCHEMBL3306396 | 0.87 | SLC6A2 (0.38) | SLC6A2SLC6A4SLC6A3MLNRADRB2 | |
| SCHEMBL2635584 | 0.84 | SLC6A2 (0.37) | SLC6A2SLC6A4SLC6A3MLNRADRB2 | |
| SCHEMBL27793824 | 0.84 | SLC6A2 (0.40) | SLC6A2SLC6A4SLC6A3MLNRADRB2 | |
| SCHEMBL3304969 | 0.82 | SLC6A2 (0.36) | SLC6A2SLC6A4SLC6A3MLNRADRB2 | |
| SCHEMBL557367 | 0.81 | SLC6A2 (0.42) | SLC6A2SLC6A4SLC6A3MLNRADRB2 | |
| SCHEMBL3308649 | 0.81 | SLC6A2 (0.39) | SLC6A2SLC6A4SLC6A3MLNRADRB2 | |
| SCHEMBL49735 | 0.80 | — | — | |
| SCHEMBL13745155 | 0.79 | SLC6A2 (0.38) | SLC6A2SLC6A4SLC6A3MLNRADRB2 | |
| Hydrochloric Acid SCHEMBL20424103 | 0.79 | SLC6A2 (0.37) | SLC6A2SLC6A4SLC6A3MLNRADRB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2017184428-A1 | CORROSION INHIBITING FORMULATION FOR DRILLING FLUID BRINES | Lubrizol Oilfield Solutions, Inc. (US) | 2017-10-26 | — | — | WO | claimed |
| US-5429672-A | Silica effect control during metal deposition | HILEMN LABORATORIES, INC. (US) | 1995-07-04 | — | — | US | claimed |
| US-11518749-B2 | Method for the continuous separation by distillation of mixtures that contain morpholine (MO), monoaminodiglycol (ADG), ammonia, water and methoxyethanol (MOE) | BASF SE (DE) | 2022-12-06 | — | — | US | disclosed |
| EP-3755691-B1 | METHOD FOR THE CONTINUOUS DESTILLATIVE SEPARATION OF MIXTURES COMPRISING MORPHOLINE (MO), MONOAMINODIGLYCOL (ADG), AMMONIA, WATER AND METHOXYETHANOL (MOE) | BASF SE (DE) | 2022-04-06 | — | — | EP | disclosed |
| EP-3755691-A1 | METHOD FOR THE CONTINUOUS SEPARATION BY DISTILLATION OF MIXTURES THAT CONTAIN MORPHOLINE (MO), MONOAMINODIGLYCOL (ADG), AMMONIA, WATER AND METHOXYETHANOL (MOE) | BASF SE (DE) | 2020-12-30 | — | — | EP | disclosed |
| US-20200392093-A1 | METHOD FOR THE CONTINUOUS SEPARATION BY DISTILLATION OF MIXTURES THAT CONTAIN MORPHOLINE (MO), MONOAMINODIGLYCOL (ADG), AMMONIA, WATER AND METHOXYETHANOL (MOE) | BASF SE (DE) | 2020-12-17 | — | — | US | disclosed |
| WO-2019162121-A1 | METHOD FOR THE CONTINUOUS SEPARATION BY DISTILLATION OF MIXTURES THAT CONTAIN MORPHOLINE (MO), MONOAMINODIGLYCOL (ADG), AMMONIA, WATER AND METHOXYETHANOL (MOE) | BASF SE (DE) | 2019-08-29 | — | — | WO | disclosed |
| EP-2077990-B1 | METHOD FOR THE CONTINUOUS SEPARATION BY DISTILLATION OF MIXTURES THAT CONTAIN MORPHOLINE (MO), MONOAMINODIGLYCOL (ADG), AMMONIA AND WATER | BASF SE (DE) | 2013-08-07 | — | — | EP | disclosed |
| US-8293075-B2 | Method for the continuous separation by distillation of mixtures that contain morphonline (MO), monoaminodiglycol (ADG), ammonia and water by means of distillation | BASF SE (DE) | 2012-10-23 | — | — | US | disclosed |
| US-8246793-B2 | Method for the continuous separation of mixtures comprising morpholine (MO), monoaminodiglycol (ADG), ammonia and water by means of distillation | BASF SE (DE) | 2012-08-21 | — | — | US | disclosed |
| US-8197646-B2 | Processes for continuous fractional distillation of mixtures comprising morpholine, monoaminodiglycol, ammonia and water | BASF SE (DE) | 2012-06-12 | — | — | US | disclosed |
| EP-0716084-A1 | Preparation of 4,4'-(oxydi-2,1-ethanediyl)bis-morpholine and hydroxyethoxyethyl morpholine | HUNTSMAN CORPORATION (US) | 1996-06-12 | — | — | EP | disclosed |
| EP-0625997-A1 | DIAMINOCARBONATE COMPOUNDS AND THEIR USE AS CATALYSTS. | RWE DEA AG (DE) | 1994-11-30 | — | — | EP | disclosed |
| WO-1993016124-A1 | DIAMINOCARBONATE COMPOUNDS AND THEIR USE AS CATALYSTS | RWE-DEA Aktiengesellschaft für Mineraloel und Chemie (DE) | 1993-08-19 | — | — | WO | disclosed |
| US-4775519-A | CONTACTING WITH COUNTERCURRENT STREAM OF AQUEOUS N-METHYLDIETHANOLAMINE AND IMIDAZOLE | TEXACO INC. (US) | 1988-10-04 | — | — | US | disclosed |
| US-4696803-A | METHYLDIETHANOLAMINE DIETHYLHYDROXYLAMINE | TEXACO INC. (US) | 1987-09-29 | — | — | US | disclosed |
| US-4439345-A | POTASSIUM OR SODIUM HYDROXIDE | MARATHON OIL COMPANY (US) | 1984-03-27 | — | — | US | disclosed |
| US-4396530-A | Mineral acid demulsification of surfactant-containing emulsion | MARATHON OIL COMPANY (US) | 1983-08-02 | — | — | US | disclosed |
| US-4095022-A | PHOSPHORUS COMPOUNDS, SILICA-ALUMINA CATALYST | TEXACO DEVELOPMENT CORPORATION (US) | 1978-06-13 | — | — | US | disclosed |
| US-4026935-A | FROM N-(HYDROXYALKYL)-MORPHOLINE COMPOUND, SILICA-ALUMINA CATALYST | TEXACO DEVELOPMENT CORPORATION (US) | 1977-05-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200392093-A1 | METHOD FOR THE CONTINUOUS SEPARATION BY DISTILLATION OF MIXTURES THAT CONTAIN MORPHOLINE (MO), MONOAMINODIGLYCOL (ADG), AMMONIA, WATER AND METHOXYETHANOL (MOE) | MYH10, MGLL, AGL | SLC6A2 1588/4885SLC6A4 1775/4885SLC6A3 1282/4885 |
| US-11518749-B2 | Method for the continuous separation by distillation of mixtures that contain morpholine (MO), monoaminodiglycol (ADG), ammonia, water and methoxyethanol (MOE) | MYH10, MGLL, AGL | SLC6A2 1588/4885SLC6A4 1775/4885SLC6A3 1282/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.